advertise

Thursday 11 June 2015

Biosimilars Regulatory Framework and Pipeline Analysis - Worldwide market Size, Share, Trend, Analysis and Research Report

Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar.

To Browse a Full Report with TOC: http://www.researchmoz.us/biosimilars-regulatory-framework-and-pipeline-analysis-report.html

It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future

Scope

The scope of the report includes:

Introduction

Market dynamics: Trends, Drivers, and Barriers

WHO guidance for biosimilars

Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for:

Europe

USA

India

South Korea

Japan

China

Key players

Pipeline Analysis

Overview

By Stage of Development / Molecule / Therapy Area / Indication

Late-Stage / Phase II / Phase I Pipeline Biosimilars

To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=sample&repid=286559

Reasons To Buy

The report will enhance your decision-making capability by allowing you to:

Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market

Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure

With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape

Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline

Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition

All Reports of this Category Here: http://www.researchmoz.us/enquiry.php?type=sample&repid=286559

About ResearchMoz

ResearchMoz
is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Email:
sales@researchmoz.us

Website @ http://www.researchmoz.us/

Blog: http://dynamicmarketresearch.blogspot.com/

Tel: 866-997-4948 (Us-Canada Toll Free)

Tel: +1-518-618-1030

No comments:

Post a Comment